American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$229M |
| 2 |
Johnson & Johnson
JNJ
|
+$202M |
| 3 |
JPMorgan Chase
JPM
|
+$193M |
| 4 |
Citizens Financial Group
CFG
|
+$174M |
| 5 |
Automatic Data Processing
ADP
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$288M |
| 2 |
Union Pacific
UNP
|
+$199M |
| 3 |
PNC Financial Services
PNC
|
+$196M |
| 4 |
NXP Semiconductors
NXPI
|
+$155M |
| 5 |
Cisco
CSCO
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.53% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 11.86% |
| 4 | Industrials | 10.85% |
| 5 | Consumer Discretionary | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Progress Software
PRGS
$1.79B
| $2.18M | ﹤0.01% |
68,296
+36,439
| +114% | +$1.06M |
|
|
BOBE
1027
DELISTED
Bob Evans Farms, Inc.
BOBE
| $2.09M | ﹤0.01% |
39,290
-95,576
| -71% | -$4.3M |
|
|
FLXN
1028
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $2.09M | ﹤0.01% |
109,761
+27,499
| +33% | +$526K |
|
|
OMN
1029
DELISTED
OMNOVA Solutions Inc.
OMN
| $2.08M | ﹤0.01% |
208,251
+61,285
| +42% | +$541K |
|
|
VAR
1030
DELISTED
Varian Medical Systems, Inc.
VAR
| $2.07M | ﹤0.01% |
26,345
-365
| -1% | -$29.5K |
|
1031
Bath & Body Works
BBWI
$3.65B
| $2.05M | ﹤0.01% |
38,533
-933,201
| -96% | -$53.1M |
|
1032
Leidos
LDOS
$17.6B
| $2.04M | ﹤0.01% |
39,995
+22,785
| +132% | +$1.07M |
|
1033
ASML
ASML
$695B
| $2.04M | ﹤0.01% |
18,196
+62
| +0.3% | +$6.49K |
|
|
JNS
1034
DELISTED
Janus Capital Group Inc
JNS
| $2.03M | ﹤0.01% |
152,718
+20,998
| +16% | +$289K |
|
|
CCMP
1035
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $2.02M | ﹤0.01% |
+31,964
| New | +$1.85M |
|
|
OSG
1036
Octave Specialty Group
OSG
$210M
| $2.02M | ﹤0.01% |
+89,574
| New | +$1.96M |
|
1037
Marcus & Millichap
MMI
$1.18B
| $2.02M | ﹤0.01% |
75,404
-92,174
| -55% | -$2.4M |
|
1038
iShares MSCI Japan ETF
EWJ
$23.1B
| $1.98M | ﹤0.01% |
40,564
-85,545
| -68% | -$4.27M |
|
|
PF
1039
DELISTED
Pinnacle Foods, Inc.
PF
| $1.96M | ﹤0.01% |
36,709
-3,581
| -9% | -$182K |
|
1040
Louisiana-Pacific
LPX
$5.15B
| $1.95M | ﹤0.01% |
+102,893
| New | +$1.96M |
|
1041
Addus HomeCare
ADUS
$2.2B
| $1.94M | ﹤0.01% |
+55,394
| New | +$1.71M |
|
|
EMCI
1042
DELISTED
EMC INS Group Inc
EMCI
| $1.94M | ﹤0.01% |
64,507
+24,570
| +62% | +$676K |
|
1043
Central Garden & Pet Co Class A
CENTA
$2.43B
| $1.91M | ﹤0.01% |
77,334
-109,416
| -59% | -$2.37M |
|
1044
Prothena Corp
PRTA
$475M
| $1.91M | ﹤0.01% |
38,807
-4,137
| -10% | -$228K |
|
1045
Corning
GLW
$144B
| $1.9M | ﹤0.01% |
78,245
-666
| -0.8% | -$15.8K |
|
1046
Park National Corp
PRK
$3.72B
| $1.89M | ﹤0.01% |
+15,831
| New | +$1.69M |
|
1047
EPR Properties
EPR
$4.7B
| $1.89M | ﹤0.01% |
26,277
-26,039
| -50% | -$1.86M |
|
|
ELLI
1048
DELISTED
Ellie Mae Inc
ELLI
| $1.83M | ﹤0.01% |
21,915
-20,124
| -48% | -$1.86M |
|
1049
Haemonetics
HAE
$4.16B
| $1.83M | ﹤0.01% |
+45,441
| New | +$1.71M |
|
|
BSTC
1050
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $1.83M | ﹤0.01% |
32,803
-2,297
| -7% | -$110K |
|
Similar funds
American Century Companies's Q4 2016 Portfolio in Review
As of Q4 2016, American Century Companies held 1,486 positions worth $92.8B, up 1.9% from $91B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
American Century Companies's Q4 2016 filing shows 166 new, 494 increased, 617 reduced and 173 closed positions. Its largest new stake was Citizens Financial Group: 5,752,874 shares worth $205M. The largest sale was Pfizer, an estimated $288M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
- American Century Companies's largest Q4 2016 buy was Citizens Financial Group: 5,752,874 shares worth $205M.
- American Century Companies added most to Chevron in Q4 2016, an estimated $229M increase.
- American Century Companies's biggest Q4 2016 reduction was Pfizer, cutting an estimated $288M.
- American Century Companies fully exited Liberty Global Class A in Q4 2016, selling an estimated $116M.
- American Century Companies's ten largest holdings make up 13% of its $92.8B portfolio in Q4 2016.
- American Century Companies opened 166 new positions and closed 173 in Q4 2016.
- American Century Companies's portfolio value rose 1.9% quarter-over-quarter to $92.8B.
Based on American Century Companies's 13F filing for Q4 2016, filed 3 Feb 2017.